Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Feb 21, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different surgical methods used during lung surgery for cancer affect patients' recovery and overall quality of life. Specifically, it compares traditional surgery (where a larger cut is made in the chest) with newer, less invasive techniques that use smaller cuts and special tools, like video-assisted and robotic surgery. The goal is to understand why patients who undergo these minimally invasive surgeries seem to have fewer complications and a better recovery experience.
To be eligible for this study, participants should be between the ages of 65 and 74 and scheduled for a major lung surgery called a lobectomy. They can be part of the trial if they're having surgery using either the traditional method or the newer minimally invasive techniques, but not if they need a more extensive lung operation. While the trial is not yet recruiting participants, those who take part can expect to help researchers learn important information that may improve surgical care for lung cancer patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients admitted for major lung resection
- • Surgical approach by conventional postern-lateral thoracotomy
- • Surgical approach by minimally invasive RATS
- Exclusion Criteria:
- • - Extended lung resection
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Harry ETIENNE, M.D., PhD
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported